Articles related to BREAST CANCER

Explore the transformative potential of antibody-drug conjugates (ADCs) in cancer therapy, offering targeted treatments with reduced side effects. Recent approvals and ongoing trials signify a significant shift towards precision medicine in oncology.

This innovative device can transform breast cancer screening by providing a rapid, affordable, and non-invasive diagnostic solution, particularly beneficial in regions with limited access to traditional screening methods.

In the realm of HER2-positive early breast cancer, achieving a pathological complete response (pCR) post-neoadjuvant therapy has been linked to a markedly reduced risk of recurrence, highlighting the critical role of tailored treatment strategies in improving patient outcomes.

A recent study demonstrates AI-supported mammogram reading’s ability to detect 20% more cancers compared to traditional methods, marking a significant step forward in breast cancer screening efficiency and accuracy.

Recent findings indicate that pre-WBRT administration of bevacizumab, etoposide, and cisplatin (BEEP) may significantly improve brain-specific progression-free survival in breast cancer patients with brain metastases.

Explore how metixene, a repositioned antiparkinsonian drug, emerges as a promising agent in treating metastatic breast cancer and brain metastases, redefining therapeutic approaches in oncology.